I was thinking the same thing as Biotech, as they would appear...

I was thinking the same thing as Biotech, as they would appear to more of a competitor to Luminex. If anything they could be more of a customer.

With a propriety reagents, process and equipment I would think that they are potentially limiting themselves to more niece areas, as the end-user clinics are unlikely to limit themselves to a new technology at the expense of existing systems and platforms that are well entrenched.

Unless their propriety reagent is something extra special, their system could well use, and see benefits from, Mix&Go in binding the dyes to the target molecules.